Encompass Health Co. (NYSE:EHC) Shares Purchased by Zurcher Kantonalbank Zurich Cantonalbank

Zurcher Kantonalbank Zurich Cantonalbank lifted its holdings in Encompass Health Co. (NYSE:EHC) by 10.5% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 744,046 shares of the company’s stock after purchasing an additional 70,418 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in Encompass Health were worth $68,713,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. MassMutual Private Wealth & Trust FSB grew its holdings in shares of Encompass Health by 87.8% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company’s stock valued at $27,000 after purchasing an additional 137 shares in the last quarter. Avior Wealth Management LLC acquired a new position in Encompass Health during the 3rd quarter worth approximately $40,000. Tompkins Financial Corp acquired a new position in Encompass Health during the 4th quarter worth approximately $46,000. V Square Quantitative Management LLC grew its holdings in Encompass Health by 43.8% during the 4th quarter. V Square Quantitative Management LLC now owns 581 shares of the company’s stock worth $54,000 after acquiring an additional 177 shares in the last quarter. Finally, Morse Asset Management Inc acquired a new position in Encompass Health during the 3rd quarter worth approximately $68,000. Institutional investors and hedge funds own 97.25% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have commented on the stock. KeyCorp boosted their price target on shares of Encompass Health from $117.00 to $120.00 and gave the stock an “overweight” rating in a report on Monday, February 10th. William Blair reiterated an “outperform” rating on shares of Encompass Health in a report on Friday, February 7th. Royal Bank of Canada reiterated an “outperform” rating and set a $110.00 price target on shares of Encompass Health in a report on Tuesday, February 11th. StockNews.com upgraded shares of Encompass Health from a “hold” rating to a “buy” rating in a report on Saturday, February 15th. Finally, Barclays upped their target price on shares of Encompass Health from $116.00 to $118.00 and gave the company an “overweight” rating in a report on Friday, February 7th. Ten equities research analysts have rated the stock with a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat.com, Encompass Health has an average rating of “Buy” and a consensus target price of $107.67.

Encompass Health Stock Down 0.5 %

EHC stock opened at $99.20 on Monday. The company has a fifty day moving average price of $96.95 and a 200 day moving average price of $96.80. Encompass Health Co. has a 12 month low of $74.27 and a 12 month high of $104.55. The company has a market cap of $9.99 billion, a price-to-earnings ratio of 22.24, a price-to-earnings-growth ratio of 2.31 and a beta of 0.92. The company has a debt-to-equity ratio of 0.84, a current ratio of 1.05 and a quick ratio of 1.04.

Encompass Health (NYSE:EHC) last announced its quarterly earnings data on Thursday, February 6th. The company reported $1.17 EPS for the quarter, topping analysts’ consensus estimates of $1.05 by $0.12. Encompass Health had a net margin of 8.48% and a return on equity of 17.56%. Sell-side analysts expect that Encompass Health Co. will post 4.8 earnings per share for the current year.

Encompass Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 15th. Shareholders of record on Tuesday, April 1st will be given a dividend of $0.17 per share. The ex-dividend date of this dividend is Tuesday, April 1st. This represents a $0.68 dividend on an annualized basis and a yield of 0.69%. Encompass Health’s payout ratio is currently 15.25%.

Insiders Place Their Bets

In other Encompass Health news, CAO Andrew L. Price sold 5,042 shares of the company’s stock in a transaction on Thursday, February 13th. The shares were sold at an average price of $98.29, for a total transaction of $495,578.18. Following the completion of the transaction, the chief accounting officer now owns 69,164 shares in the company, valued at approximately $6,798,129.56. This represents a 6.79 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 2.10% of the stock is owned by insiders.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.